Keyword: Morphosys


Novartis Acquires Morphosys for €2.7 Billion in Cash

06.02.2024 -

Novartis recently announced its agreement to acquire Morphosys AG, a Germany-based biopharmaceutical company specializing in oncology medicines. This strategic move...

Strategy & Management

The Art of the Alliance

04.04.2016 - Alliances between big pharma and scientists, hospitals and biotech firms are common practice in the health-care business. About half of today’s top-selling drugs are the result of...


Roche Alzheimer and Breast Cancer Drugs Hit Snags

22.12.2014 - Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease...


Merck KGaA and MorphoSys in Joint Antibody R&D

13.06.2014 - Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...